03:36:39 EDT Tue 03 Oct 2023
Enter Symbol
or Name

Login ID:

News for U:TCBP from 2022-10-04 to 2023-10-03 - 26 items News ReleasesIn The NewsOther CAUS
2023-09-27 08:00U:TCBPNews ReleaseTC BioPharm to Present at the LD Micro Main Event XVI
2023-09-05 08:30U:TCBPNews ReleaseTC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL)
2023-08-29 08:30U:TCBPNews ReleaseTC BioPharm to Present at H.C. Wainwright 25th Annual Global Investment Conference
2023-07-31 08:30U:TCBPNews ReleaseTC BioPharm Maintains Nasdaq Listing
2023-05-24 09:00U:TCBPNews ReleaseTC BioPharm to Present at LD Micro Invitational XIII Conference on June 7, 2023
2023-04-26 08:30U:TCBPNews ReleaseTC BioPharm Increases Allogeneic Car and Partnering Focus for Advancement of TCB-008
2023-04-19 08:00U:TCBPNews ReleaseTC BioPharm to Present at the Sequire Investor Summit in Puerto Rico
2023-03-30 16:15U:TCBPNews ReleaseTC BioPharm Announces Closing of $5.5 Million Public Offering
2023-03-28 08:05U:TCBPNews ReleaseTC BioPharm Announces Pricing of $5.5 Million Public Offering
2023-03-22 08:30U:TCBPNews ReleaseTC Biopharm Announces Corporate Restructuring, Reduction in Overhead
2023-03-16 12:00U:TCBPNews ReleaseTC BioPharm Receives Extension from Nasdaq Hearings Panel to Regain Compliance With Listing Rule 5550(b)(2)
2023-03-07 08:30U:TCBPNews ReleaseTC BioPharm Shifts Focus to FDA Clinical Trials
2023-02-23 08:30U:TCBPNews ReleaseTC BioPharm Announces Dr. Mike Leek as Chief Technology Officer
2023-02-21 08:30U:TCBPNews ReleaseTC BioPharm Announces Publication of Paper in AML Research Highlighting the Company's Development of Allogeneic Gamma-Delta T cell Therapies
2023-02-14 08:30U:TCBPNews ReleaseTC BioPharm Announces New Chair of the Board, Arlene Morris
2023-02-13 16:15U:TCBPNews ReleaseTC BioPharm to Reschedule Shareholder Update Call and Webcast
2023-02-07 08:30U:TCBPNews ReleaseTC BioPharm Announces Successful Dosing of Final Patient in ACHIEVE Safety Cohort
2023-01-30 08:30U:TCBPNews ReleaseTC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
2023-01-20 08:30U:TCBPNews ReleaseTC BioPharm to Host Shareholder Update Call
2023-01-19 08:30U:TCBPNews ReleaseTC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1)
2023-01-17 08:30U:TCBPNews ReleaseTC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
2022-12-12 09:00U:TCBPNews ReleaseTC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update
2022-11-30 18:43U:TCBPNews ReleaseTC BioPharm Announces Closing of $7.35 Million Private Placement
2022-11-28 08:00U:TCBPNews ReleaseTC BioPharm Announces $7.35 Million Private Placement
2022-11-22 08:00U:TCBPNews ReleaseTC BioPharm Begins Dosing Phase 2B Clinical Study Evaluating its Lead Compound, OmnImmune ‚ ®, in Patients with Acute Myeloid Leukemia
2022-10-26 08:30U:TCBPNews ReleaseTC BioPharm Announces Key Additions to Scientific Advisory Board, Expanding Cell Therapy Expertise